Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / Companies / Gilead Sciences
Company

Gilead Sciences

Tracked across 8 events · 119 articles · First seen Feb 10, 2025 · Last active Jul 05, 2026

Sentiment
30
Attention
8
Events
8
Relationships
84
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (8)
6 70
Business
Gilead Sciences Acquires Tubulis for $5B
Impact: Gilead Sciences is acquiring Tubulis for up to $5.0 billion, gaining its next-generation antibody-drug conjugate platform and pipeline, which will enhance Gilead's oncology capabilities.
Apr 07, 2026 · 6 articles
6 20
Regulatory
Trump Secures Drug Price Deals
Impact: Gilead Sciences is among the pharmaceutical companies that agreed to lower drug prices for United States — Medicaid and cash payers as part of the deals with the Donald Trump administration.
Dec 19, 2025 · 7 articles
8 60
Business
Biotech M&A Surges Amid Patent Cliffs
Impact: Gilead Sciences is a pharmaceutical company that has been actively involved in acquisitions this year and is also facing patent expirations on some of its blockbuster drugs.
May 01, 2026 · 6 articles
6 50
Tech
Ebola Treatment Trial Begins DRC
Impact: Gilead Sciences is the developer of remdesivir, one of the antiviral drugs being evaluated in the clinical trial for Ebola. The company has donated doses of the drug for the study.
Apr 20, 2026 · 67 articles
6 40
Tech
WHO Lists Bundibugyo Ebola Test
Impact: Gilead Sciences' antiviral drug remdesivir is being evaluated in combination with Mapp Biopharmaceutical's MBP134 antibody in a treatment trial for the Bundibugyo Ebola outbreak.
Jul 02, 2026 · 8 articles
6 0
Tech
Africa Rolls Out Lenacapavir HIV Prevention
Dec 01, 2025 · 6 articles
6 0
Business
Gilead Sciences Acquires Tubulis
Apr 07, 2026 · 6 articles
2 0
Domestic
Rutgers Cancels Rami Elghandour Speech
May 06, 2026 · 13 articles
Key Actions (1)
75 Gilead Sciences donated drugEbola Treatment Trial Begins DRC
Relationships (84)
Mapp Biopharmaceutical ↔ Gilead Sciences
Mapp Biopharmaceutical ↔ Gilead Sciences
International Federation of Red Cross and Red Crescent Societies ↔ Gilead Sciences
Félix Tshisekedi ↔ Gilead Sciences
Tom Ksiazek ↔ Gilead Sciences
Anne Ancelin Schützenberger ↔ Gilead Sciences
ALIMA ↔ Gilead Sciences
International Federation of Red Cross and Red Crescent Societies ↔ Gilead Sciences
Félix Tshisekedi ↔ Gilead Sciences
Tom Ksiazek ↔ Gilead Sciences
Anne Ancelin Schützenberger ↔ Gilead Sciences
ALIMA ↔ Gilead Sciences
International AIDS Vaccine Initiative ↔ Gilead Sciences
Coalition for Epidemic Preparedness Innovations ↔ Gilead Sciences
International AIDS Vaccine Initiative ↔ Gilead Sciences
Coalition for Epidemic Preparedness Innovations ↔ Gilead Sciences
March 23 Movement ↔ Gilead Sciences
March 23 Movement ↔ Gilead Sciences
India — National Geophysical Research Institute ↔ Gilead Sciences
International Red Cross and Red Crescent Movement ↔ Gilead Sciences
India — National Geophysical Research Institute ↔ Gilead Sciences
International Red Cross and Red Crescent Movement ↔ Gilead Sciences
Vasee Moorthy ↔ Gilead Sciences
Vasee Moorthy ↔ Gilead Sciences
Jean Kaseya ↔ Gilead Sciences
Jean Kaseya ↔ Gilead Sciences
Serum Institute of India ↔ Gilead Sciences
Jean-Jacques Muyembe-Tamfum ↔ Gilead Sciences
Roger Kamba ↔ Gilead Sciences
Syrian Democratic Forces ↔ Gilead Sciences
+ 54 more relationships View on Dashboard
ERGEN INTELLIGENCE
Track Gilead Sciences live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.